IN-VITRO TBG RADIOIMMUNOASSAY TEST— 510(k) K810967
Substantially EquivalentClinical Assays, Inc.
FDA 510(k) clearance K810967 for IN-VITRO TBG RADIOIMMUNOASSAY TEST, Substantially Equivalent on 1981-04-23. Applicant: Clinical Assays, Inc.. Device class: 2.
Clearance details
- Applicant
- Clinical Assays, Inc.
- Product code
- Code CEE
- Device class
- Class 2
- Regulation
- 21 CFR 862.1685
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Mchenry, IL, US
Recent devices under product code CEE
view allMore clearances from Clinical Assays, Inc.
view allData sourced from openFDA. This site is unofficial and independent of the FDA.